{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-062023","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.048755+00:00","generated_at":"2026-06-08T07:41:32.580820+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Teknova Q3 revenue $8.2M, down 24% YoY; net loss $10.2M; raised $22.9M equity, trimmed debt","bullets":["Q3 revenue $8.2M (-24% YoY); Lab Essentials $7.3M (-23%), Clinical Solutions $0.6M (-35%).","Net loss $10.2M ($0.34/share) vs $22.5M ($0.80/share) prior year; adjusted EBITDA -$5.5M.","Gross margin fell to 18.0% from 44.6% due to lower revenue and fixed cost underabsorption.","Raised $22.9M equity capital; repaid $10.0M long-term debt; expects FY free cash outflow <$30M.","FY2023 revenue now expected at low end of $37-40M guidance range."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-062023","json":"https://secwatch.observer/filing/0000950170-23-062023.json","markdown":"https://secwatch.observer/filing/0000950170-23-062023.md","text":"https://secwatch.observer/filing/0000950170-23-062023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000095017023062023/0000950170-23-062023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000095017023062023/tkno-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:41:32.580820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a0dc16ee746304b5989347659751ecce304c4df5","claim":"Alpha Teknova, Inc. reported the third quarter ended September 30, 2023 results: revenue total revenue was $8.2 million, net income Net loss for the third quarter 2023 was $10.2 million, or negative $0.34 per diluted share, EPS negative $0.34 per diluted share. Guidance lowered.","evidence_excerpt":"99.1 Teknova Reports Third Quarter 2023 Financial Results Raised $22.9 million of equity capital, paid down $10.0 million of long-term debt Third quarter 2023 total revenue was $8.2 million, down 24% from prior year Expect 2023 revenue at the low end of previously announced guidance range of $37-40 million HOLLISTER, Calif., November 9, 2023 – Alpha Teknova, Inc.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850902/000095017023062023/0000950170-23-062023-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"total revenue was $8.2 million"},{"label":"Net income","value":"Net loss for the third quarter 2023 was $10.2 million, or negative $0.34 per diluted share"},{"label":"EPS","value":"negative $0.34 per diluted share"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}